Company record · VRTX

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated disclosed a change in its chief financial officer, effective January 1, 2027; the incoming officer named in the filing is Jonathan Poole. Until then the filing lists Charles F. Wagner, Jr. in the role. See the filing record.

Tracked changes

2026-09-01

Vertex Pharmaceuticals Incorporated CFO transition: Jonathan Poole to succeed Charles F. Wagner, Jr.

This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.